[go: up one dir, main page]

McCurdy, 2011 - Google Patents

Quality by design

McCurdy, 2011

Document ID
5192607863583634478
Author
McCurdy V
Publication year
Publication venue
Process Understanding: For Scale‐Up and Manufacture of Active Ingredients

External Links

Snippet

The pharmaceutical industry has been a highly regulated industry in the past for many good reasons [1]. While pharmaceuticals have greatly improved the mortality and morbidity rates, there is still some element of risk to the patients. These risks are greatly mitigated with the …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/324—Management of patient independent data, e.g. medical references in digital format
    • G06F19/326—Medication information, e.g. drug reference databases
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
    • G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation

Similar Documents

Publication Publication Date Title
McCurdy Quality by design
Riley et al. Specification of drug substances and products: development and validation of analytical methods
US12221602B2 (en) Predicting bioreactor product production based on independent or multivariate analysis of multiple physical attributes
Dolgikh et al. QSAR model of unbound brain-to-plasma partition coefficient, K p, uu, brain: incorporating p-glycoprotein efflux as a variable
US9977846B2 (en) Product quality control method
Igne et al. Near-infrared spectroscopy in the pharmaceutical industry
Koeberle et al. QbD: improving pharmaceutical development and manufacturing workflows to deliver better patient outcomes
Amarji et al. Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization
Talwar et al. NIR spectroscopy as an online PAT tool for a narrow therapeutic index drug: Toward a platform approach across lab and pilot scales for development of a powder blending monitoring method and endpoint determination
DeRidder et al. Closed-loop automated drug infusion regulator: A clinically translatable, closed-loop drug delivery system for personalized drug dosing
Yang et al. Intravenous compounding robots in pharmacy intravenous admixture services: a systematic review
Little Evaluating design margin, edge of failure, and process capability
Hart et al. Real-time monitoring and control of critical process impurities during the manufacture of fostamatinib disodium
Wan et al. An accurate prediction of the physicochemical properties of traditional Chinese medicine granules using a multi-source data model fusion strategy based on deep ensemble learning algorithms
Ghante et al. Six-Sigma Model in Pharma Industry: Part–II
Kumari et al. Applications of quality by design in pharmaceutical product development lifecycle
McElderry et al. In-line phosphoramidite identification by FTIR to support real-time oligonucleotide sequence confirmation
Siew Designing optimized formulations
CN114155978A (en) Pharmacokinetic analysis method for monitoring therapeutic drug
Isaacs et al. Spectral intra-lot and inter-lot variability in carfilzomib
Alsamil et al. Post-approval quality-related regulatory actions for biopharmaceuticals approved in the European Union and the United States between 1995 and 2019
Alam et al. Quality by design-a recent trend in pharmaceutical industries
Dumpala et al. Quality by Design: A Present to Future Perspective
Mishra et al. QbD: Review of a revolutionary approach for quality products
Bhadoriya Quality by design–A Systematic Approach to Enhance Quality Matrix